Trial · NCT03275402
Adverse events46
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 46
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | 131I-omburtamab | 15 | 52 | 22 |
| other | Tachycardia | Cardiac disorders | 131I-omburtamab | 4 | 52 | 10 |
| other | Hypothyroidism | Endocrine disorders | 131I-omburtamab | 4 | 52 | 4 |
| other | Abdominal pain | Gastrointestinal disorders | 131I-omburtamab | 4 | 52 | 4 |
| other | Constipation | Gastrointestinal disorders | 131I-omburtamab | 3 | 52 | 3 |
| other | Diarrhoea | Gastrointestinal disorders | 131I-omburtamab | 3 | 52 | 3 |
| other | Nausea | Gastrointestinal disorders | 131I-omburtamab | 19 | 52 | 21 |
| other | Vomiting | Gastrointestinal disorders | 131I-omburtamab | 18 | 52 | 25 |
| other | Fatigue | General disorders | 131I-omburtamab | 4 | 52 | 4 |
| other | Pain | General disorders | 131I-omburtamab | 6 | 52 | 20 |
| other | Pyrexia | General disorders | 131I-omburtamab | 8 | 52 | 9 |
| other | Contusion | Injury, poisoning and procedural complications | 131I-omburtamab | 3 | 52 | 3 |
| other | Alanine aminotransferase increased | Investigations | 131I-omburtamab | 4 | 52 | 4 |
| other | Aspartate aminotransferase increased | Investigations | 131I-omburtamab | 3 | 52 | 4 |
| other | Lymphocyte count decreased | Investigations | 131I-omburtamab | 16 | 52 | 19 |
| other | Neutrophil count decreased | Investigations | 131I-omburtamab | 22 | 52 | 43 |
| other | Platelet count decreased | Investigations | 131I-omburtamab | 22 | 52 | 26 |
| other | Protein total decreased | Investigations | 131I-omburtamab | 3 | 52 | 3 |
| other | White blood cell count decreased | Investigations | 131I-omburtamab | 23 | 52 | 34 |
| other | Decreased appetite | Metabolism and nutrition disorders | 131I-omburtamab | 6 | 52 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03275402/events